Semaglutide is a medication that has recently been approved by the FDA for weight loss in adults with a body mass index (BMI) of 30 or greater, or those with a BMI of 27 or greater with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.


How Semaglutide Works

Semaglutide works by mimicking the GLP-1 agonist that crosses the blood-brain barrier, influencing appetite regulation and food intake. This innovative treatment has been met with great excitement, with many medical professionals, including Dr. Scott Gerrish, witnessing impressive results in combination with healthy lifestyle changes.

At our medical spa, we are eager to partner with you on your weight loss or maintenance journey and see if Semaglutide, (commonly known as Ozempic, Wegovy or Rybelsus) can be a helpful tool. Life is beautiful and taking control of your health can make it even more so.

Dr. Scott Gerrish, Medical Director for Faces Med Spa says, “Semaglutide represents a new approach to weight loss that goes beyond just calorie restriction and exercise. It targets the biological mechanisms that regulate appetite and food intake, helping patients achieve sustainable weight loss. This medication has the potential to revolutionize the field of obesity medicine and improve the health outcomes of millions of people around the world and I delighted to help my patients achieve their body and wellness goals.”


Semaglutide is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It should also be avoided during pregnancy or breastfeeding. People with a history of pancreatitis should use semaglutide with caution

Some common side effects of semaglutide include nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects usually go away on their own or with dose adjustments. There is also a risk of more serious side effects such as pancreatitis and thyroid cancer, although these are rare.

Clinical studies have shown that semaglutide can lead to significant weight loss in people with obesity or overweight. In a 68-week study, participants who took semaglutide lost an average of 15% of their body weight, compared to 2.4% for those who took a placebo.

Semaglutide works by mimicking the effects of a hormone called GLP-1 in the body. This hormone regulates appetite and food intake. By activating the GLP-1 receptors in the brain, semaglutide can reduce hunger and promote feelings of fullness, leading to a reduced calorie intake and weight loss

Semaglutide is a medication that belongs to a class of drugs called GLP-1 receptor agonists. It is used to treat type 2 diabetes and has recently been approved by the FDA for weight management in adults with obesity or overweight with at least one weight-related health condition.